Cargando…
Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains
PURPOSE: Cefmetazole (CMZ), a cephamycin antibiotic, is primarily used as a definitive therapy for Extended Spectrum β-Lactamase (ESBL)-producing Escherichia coli infections. However, the mechanism of CMZ resistance in E. coli is still unknown. To elucidate the resistance mechanism and to determine...
Autores principales: | Ito, Ryota, Kawamura, Masato, Sato, Takumi, Fujimura, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553235/ https://www.ncbi.nlm.nih.gov/pubmed/36237294 http://dx.doi.org/10.2147/IDR.S382142 |
Ejemplares similares
-
A Response to Research Article “Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022) -
The Drug-Specific Propensity Regarding the Acquisition of Fluoroquinolone Resistance in Escherichia coli: An in vitro Challenge and DNA Mutation Analysis
por: Sato, Takumi, et al.
Publicado: (2023) -
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
por: Fukuchi, Takahiko, et al.
Publicado: (2016) -
658. Evaluation of Effectiveness of Cefmetazole vs Meropenem for Invasive Urinary Tract Infections Caused by ESBL-Producing Escherichia coli: A Prospective Multicenter Observational Study
por: Hayakawa, Kayoko, et al.
Publicado: (2022) -
Overproduction of Chromosomal ampC β-Lactamase Gene Maintains Resistance to Cefazolin in Escherichia coli Isolates
por: Kawamura, Masato, et al.
Publicado: (2022)